| Nrf2/Keap1/ARE signaling: Towards specific regulation AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev Life sciences 291, 120111, 2022 | 185 | 2022 |
| Targeted intracellular delivery of antibodies: the state of the art TA Slastnikova, AV Ulasov, AA Rosenkranz, AS Sobolev Frontiers in pharmacology 9, 411487, 2018 | 183 | 2018 |
| Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy AV Ulasov, YV Khramtsov, GA Trusov, AA Rosenkranz, ED Sverdlov, ... Molecular Therapy 19 (1), 103-112, 2011 | 117 | 2011 |
| Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression AA Rosenkranz, TA Slastnikova, TA Karmakova, MS Vorontsova, ... Frontiers in pharmacology 9, 1331, 2018 | 52 | 2018 |
| Subcellular trafficking and transfection efficacy of polyethylenimine–polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1 MO Durymanov, EA Beletkaia, AV Ulasov, YV Khramtsov, GA Trusov, ... Journal of controlled release 163 (2), 211-219, 2012 | 45 | 2012 |
| Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer IV Alekseenko, EV Snezhkov, IP Chernov, VV Pleshkan, VK Potapov, ... Journal of translational medicine 13, 1-16, 2015 | 40 | 2015 |
| Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters TA Slastnikova, AA Rosenkranz, NB Morozova, MS Vorontsova, ... International journal of nanomedicine, 395-410, 2017 | 35 | 2017 |
| Transcription factors: Time to deliver AV Ulasov, AA Rosenkranz, AS Sobolev Journal of Controlled Release 269, 24-35, 2018 | 33 | 2018 |
| Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment AA Rosenkranz, AV Ulasov, TA Slastnikova, YV Khramtsov, AS Sobolev Biochemistry (Moscow) 79, 928-946, 2014 | 24 | 2014 |
| Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue MO Durymanov, TA Slastnikova, AI Kuzmich, YV Khramtsov, AV Ulasov, ... Biomaterials 34 (38), 10209-10216, 2013 | 24 | 2013 |
| Targeted delivery of 111In into the nuclei of EGFR overexpressing cells via modular nanotransporters with anti-EGFR affibody TS Karyagina, AV Ulasov, TA Slastnikova, AA Rosenkranz, TN Lupanova, ... Frontiers in Pharmacology 11, 506349, 2020 | 22 | 2020 |
| Low-resolution structures of modular nanotransporters shed light on their functional activity YV Khramtsov, AD Vlasova, AV Vlasov, AA Rosenkranz, AV Ulasov, ... Acta Crystallographica Section D: Structural Biology 76 (12), 1270-1279, 2020 | 14 | 2020 |
| Investigation of transport and unpacking mechanisms of polyplexes for transfection efficacy on different cell lines GA Trusov, AV Ulasov, EA Beletkaia, YV Khramtsov, MO Durymanov, ... Doklady. Biochemistry and biophysics 437 (1), 77, 2011 | 9 | 2011 |
| Delivery of antibody-like molecules, monobodies, capable of binding with SARS-CoV-2 virus nucleocapsid protein, into target cells YV Khramtsov, AV Ulasov, TN Lupanova, GP Georgiev, AS Sobolev Doklady Biochemistry and Biophysics 506 (1), 220-222, 2022 | 6 | 2022 |
| Characterization of new modular nanotransporters with albumin-binding domain YV Khramtsov, AV Ulasov, AD Tsvetkova, AA Rosenkranz, GP Georgiev, ... Doklady Biochemistry and Biophysics 472, 81-83, 2017 | 6 | 2017 |
| Targeted intracellular delivery of antibodies: the state of the art. Front Pharmacol. 2018 TA Slastnikova, AV Ulasov, AA Rosenkranz | 6 | |
| Modular nanotransporter with P21 fragment inhibits DNA repair after bleomycin treatment TR Kamaletdinova, AA Rosenkranz, AV Ulasov, YV Khramtsov, ... Doklady Biochemistry and Biophysics 479, 95-97, 2018 | 5 | 2018 |
| MNT optimization for intracellular delivery of antibody fragments AV Ulasov, YV Khramtsov, TN Lupanova, AD Tsvetkova, AA Rosenkranz, ... Doklady Biochemistry and Biophysics 479, 62-65, 2018 | 5 | 2018 |
| Study of biodistribution of the modular nanotransporters after systemic administration in murine cloudman S91 melanoma model YV Khramtsov, AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev Doklady Biochemistry and Biophysics 478, 55-57, 2018 | 5 | 2018 |
| An approach to evaluate the effective cytoplasmic concentration of bioactive agents interacting with a selected intracellular target protein YV Khramtsov, AV Ulasov, AA Rosenkranz, TA Slastnikova, TN Lupanova, ... Pharmaceutics 15 (2), 324, 2023 | 4 | 2023 |
Alexander S. SobolevInstitute of Gene Biology; Moscow State UniversityVerified email at genebiology.ru
